• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Brightside Health Welcomes Jeff Margolis and David Shulkin to Board of Directors, Advisors

    12/6/22 9:01:00 AM ET
    $ALHC
    $NXGN
    Medical Specialities
    Health Care
    EDP Services
    Technology
    Get the next $ALHC alert in real time by email

    Health industry experts to provide counsel amid company's rapid growth and broader telemental health adoption

    Brightside Health, a telehealth platform that delivers life-changing mental health care to individuals with mild-to-severe clinical depression, anxiety, and other mood disorders, announced today the appointment of health industry experts Jeff Margolis as an independent board member and The Honorable David Shulkin, MD, as an advisor, effective October 1, 2022. Margolis and Secretary Shulkin will provide guidance to the organization as it expands and continues to deliver life-changing mental healthcare to all who need it, including those with elevated suicide risk.

    "We're pleased to welcome Jeff Margolis to our Board of Directors and Secretary David Shulkin as an Advisor to Brightside Health at a time when there is a profound need for telehealth solutions that treat people with more severe mental health conditions," said Brad Kittredge, co-founder and CEO, Brightside Health. "As Brightside Health continues executing on its next phase of growth, we're confident that Jeff and David will help us partner with healthcare stakeholders to reach those who need timely, high-quality care the most."

    Margolis is the former CEO and chairman of Welltok, the leading healthcare consumer activation company, and previously was the founder, chairman, and CEO of TriZetto, the first industry vertical SaaS enterprise solution supporting over 130 million insured lives. Margolis currently serves on the board of directors for NextGen Healthcare (NASDAQ:NXGN), Alignment Healthcare (NASDAQ:ALHC), TriNetX, Hydrogen Health, DNAnexus, and Grin. He also serves on several nonprofit boards including Hoag Clinic (Chair) and the Center for Digital Transformation (Chair) at the University of California, Irvine. He is also a senior advisor to Blackstone. Margolis is an alumnus of the University of Illinois, holds a CPA certificate (inactive) and an AICPA Chartered Global Management Accountant designation, and is an NACD Board Leadership Fellow.

    "Behavioral health has taken center stage as one of the certain growth segments in healthcare, and Brightside Health is best positioned in the vital area of high-cost, high-complexity mental health," said Margolis. "I am excited to join the Brightside Health board as the company focuses on converging and scaling digital technology and high-acuity services to deliver excellent customer experiences that help people improve their mental health status; create convenience for provider referrals; and reduce costs for consumers, employers, and health plans."

    Secretary Shulkin was the ninth secretary of the U.S. Department of Veterans Affairs (VA) in the Trump Administration and the VA's Under Secretary of Health in the Obama Administration. Shulkin is a widely-respected healthcare executive having served as chief executive of leading hospitals and health systems including Beth Israel in New York City and Morristown Medical Center in Northern New Jersey. He ​​founded and served as the chairman and CEO of DoctorQuality, one of the first consumer-oriented sources of information for quality and safety in healthcare. Secretary Shulkin has served on boards of managed care companies, technology companies, and healthcare organizations and now works with healthcare organizations that are leading the transformation of medicine around the world. Over his career, Secretary Shulkin has been named "One Hundred Most Influential People in American Healthcare" by Modern Healthcare and continues to advocate on behalf of the country's veterans by serving on the board of numerous nonprofits that serve veterans.

    "The ability to deliver high-quality accessible behavioral healthcare is essential to improving healthcare for our communities," said Secretary Shulkin. "Brightside Health is doing just this and this work is both important and exciting to be part of."

    The appointment of Margolis and Secretary Shulkin reinforces Brightside Health's position as the leading provider of virtual mental health care. Their guidance will support Brightside Health in their next phase of growth, helping with strategic decisions and market execution that best serve the company's members and enhance its value proposition.

    For more information about Brightside Health, visit www.brightside.com.

    About Brightside Health

    Brightside Health delivers life-changing mental health care to people with mild to severe clinical depression, anxiety, and other mood disorders, including those with elevated suicide risk. Powered by proprietary AI, purpose-built technology, and a world-class clinician network, Brightside combines precision psychiatry and leading-edge therapeutic techniques to improve patient outcomes across the entire clinical spectrum, affordably and at scale. Brightside Health can be paid for with insurance in all 50 states and DC, with appointments available in 48 hours or less. Learn more at www.brightside.com.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20221206005266/en/

    Get the next $ALHC alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ALHC
    $NXGN

    CompanyDatePrice TargetRatingAnalyst
    Alignment Healthcare Inc.
    $ALHC
    11/24/2025$20.00Neutral → Overweight
    Analyst
    Alignment Healthcare Inc.
    $ALHC
    10/14/2025$21.00Buy
    Goldman
    Alignment Healthcare Inc.
    $ALHC
    8/25/2025$21.00Sector Weight → Overweight
    KeyBanc Capital Markets
    Alignment Healthcare Inc.
    $ALHC
    7/31/2025$13.00Underweight → Equal Weight
    Barclays
    Alignment Healthcare Inc.
    $ALHC
    12/3/2024$13.00 → $17.00Equal-Weight → Overweight
    Stephens
    Alignment Healthcare Inc.
    $ALHC
    10/11/2024Sector Weight
    KeyBanc Capital Markets
    Alignment Healthcare Inc.
    $ALHC
    5/30/2024$10.00Outperform
    Robert W. Baird
    Alignment Healthcare Inc.
    $ALHC
    5/30/2024$7.75 → $11.00Neutral → Buy
    BofA Securities
    More analyst ratings

    $ALHC
    $NXGN
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Alignment Healthcare upgraded by Analyst with a new price target

    Analyst upgraded Alignment Healthcare from Neutral to Overweight and set a new price target of $20.00

    11/24/25 8:06:33 AM ET
    $ALHC
    Medical Specialities
    Health Care

    Goldman initiated coverage on Alignment Healthcare with a new price target

    Goldman initiated coverage of Alignment Healthcare with a rating of Buy and set a new price target of $21.00

    10/14/25 8:46:39 AM ET
    $ALHC
    Medical Specialities
    Health Care

    Alignment Healthcare upgraded by KeyBanc Capital Markets with a new price target

    KeyBanc Capital Markets upgraded Alignment Healthcare from Sector Weight to Overweight and set a new price target of $21.00

    8/25/25 8:07:20 AM ET
    $ALHC
    Medical Specialities
    Health Care

    $ALHC
    $NXGN
    SEC Filings

    View All

    SEC Form 424B7 filed by Alignment Healthcare Inc.

    424B7 - Alignment Healthcare, Inc. (0001832466) (Filer)

    3/3/26 3:13:17 PM ET
    $ALHC
    Medical Specialities
    Health Care

    SEC Form S-3ASR filed by Alignment Healthcare Inc.

    S-3ASR - Alignment Healthcare, Inc. (0001832466) (Filer)

    3/2/26 4:23:07 PM ET
    $ALHC
    Medical Specialities
    Health Care

    SEC Form 10-K filed by Alignment Healthcare Inc.

    10-K - Alignment Healthcare, Inc. (0001832466) (Filer)

    2/26/26 9:18:05 PM ET
    $ALHC
    Medical Specialities
    Health Care

    $ALHC
    $NXGN
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    $ALHC
    $NXGN
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Digital Officer Mansour Adnan R. was granted 23,441 shares (SEC Form 4)

    4 - Alignment Healthcare, Inc. (0001832466) (Issuer)

    2/23/26 5:14:30 PM ET
    $ALHC
    Medical Specialities
    Health Care

    President Maroney Dawn Christine sold $618,990 worth of shares (30,000 units at $20.63), decreasing direct ownership by 3% to 997,015 units (SEC Form 4)

    4 - Alignment Healthcare, Inc. (0001832466) (Issuer)

    2/17/26 7:53:27 PM ET
    $ALHC
    Medical Specialities
    Health Care

    Chief Human Resources Officer Wagner Andreas P. sold $455,212 worth of shares (22,238 units at $20.47), decreasing direct ownership by 12% to 169,805 units (SEC Form 4)

    4 - Alignment Healthcare, Inc. (0001832466) (Issuer)

    2/10/26 9:51:27 PM ET
    $ALHC
    Medical Specialities
    Health Care

    Kao John E bought $496,779 worth of shares (103,000 units at $4.82), increasing direct ownership by 4% to 2,745,253 units (SEC Form 4)

    4 - Alignment Healthcare, Inc. (0001832466) (Issuer)

    3/18/24 5:27:36 PM ET
    $ALHC
    Medical Specialities
    Health Care

    $ALHC
    $NXGN
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Alignment Healthcare Announces Pricing of Secondary Offering

    ORANGE, Calif., March 02, 2026 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (NASDAQ:ALHC) ("Alignment Healthcare" or the "Company"), an award-winning Medicare Advantage (MA) company, today announced the pricing of its previously announced underwritten public offering of 13,167,733 shares of its common stock by an affiliate of General Atlantic, L.P (the "Selling Stockholder"). The underwriter sold the shares at a public offering price of $19.46 per share. The Company will not receive any of the proceeds from the sale of the shares of its common stock being offered by the Selling Stockholder. The offering is expected to close on March 4, 2026, subject to customary closing conditions. J.P.

    3/2/26 9:05:00 PM ET
    $ALHC
    Medical Specialities
    Health Care

    Alignment Healthcare Announces Secondary Offering

    ORANGE, Calif., March 02, 2026 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (NASDAQ:ALHC) ("Alignment Healthcare" or the "Company"), an award-winning Medicare Advantage (MA) company, today announced the commencement of an underwritten public offering of 13,167,733 shares of its common stock by an affiliate of General Atlantic, L.P. (the "Selling Stockholder"). The Company will not receive any of the proceeds from the sale of the shares of its common stock being offered by the Selling Stockholder. J.P. Morgan is acting as the underwriter for the proposed offering. The offering is being made pursuant to a shelf registration statement on Form S-3, which has been filed by the Company with

    3/2/26 4:47:47 PM ET
    $ALHC
    Medical Specialities
    Health Care

    Alignment Healthcare Reports Fourth Quarter and Full-Year 2025 Results; Beats High-End of Guidance Across All Key Metrics

    Delivers full-year revenue of $3.95 billion, representing 46.1% growth year-over-year Exceeds high-end of fourth quarter and full-year guidance across all key metrics: membership, revenue, adjusted gross profit and adjusted EBITDARaises health plan membership guidance by 2,000 at the midpoint and introduces 2026 revenue guidance of $5.14 billion to $5.19 billion, representing 30%-31% growth year-over-year, and adjusted EBITDA of $133 million to $163 millionEarns recognition on the 2026 Fortune World's Most Admired Companies™ list, underscoring the company's innovative approach to senior health care ORANGE, Calif., Feb. 26, 2026 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (NASDAQ:ALHC),

    2/26/26 4:01:00 PM ET
    $ALHC
    Medical Specialities
    Health Care

    $ALHC
    $NXGN
    Leadership Updates

    Live Leadership Updates

    View All

    Alignment Health Appoints Adnan Mansour as Chief Digital Officer to Accelerate AI-Driven Growth and Technology Leadership

    ORANGE, Calif., Jan. 20, 2026 (GLOBE NEWSWIRE) -- Alignment Health, an award-winning Medicare Advantage (MA) company, today announced the appointment of Adnan Mansour as chief digital officer, an executive leadership role that unifies the company's technology and information functions to drive scalable growth and continued innovation. Mansour, formerly senior vice president and chief information officer at Optum Insight – the data, analytics and managed services division of UnitedHealth Group – brings decades of experience leading global IT and engineering teams and embedding artificial intelligence (AI) into complex health care systems. Effective Jan. 19, Mansour reports to Alignment Hea

    1/20/26 8:00:00 AM ET
    $ALHC
    Medical Specialities
    Health Care

    Alignment Healthcare Names Matt Eyles Executive Vice President of Government & Business Strategy

    ORANGE, Calif., Sept. 08, 2025 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (NASDAQ:ALHC) today announced that Matt Eyles will join as executive vice president of government and business strategy, effective Sept. 29. In this newly created position, Eyles will report directly to Alignment founder and CEO John Kao, elevating Alignment's engagement and leadership in health care policy at federal and state levels, leading innovative business planning to anticipate changes in the health care environment to drive growth, and developing new initiatives and partnerships aligned with enterprise priorities. "With Alignment's growing influence and impact, Matt's appointment comes at exactly the ri

    9/8/25 8:00:00 AM ET
    $ALHC
    Medical Specialities
    Health Care

    Alignment Healthcare Founder and CEO John Kao Named to AHIP Board

    ORANGE, Calif., June 10, 2025 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (NASDAQ:ALHC) announced today that founder and CEO John Kao was elected to the AHIP board of directors, effective June 5, 2025. AHIP is a national business organization whose member companies provide health care coverage, services and solutions to millions of Americans every day. "I'm honored to join the AHIP board and collaborate with leaders across the industry who are committed to making health care work better for more Americans," said Kao. "The industry is at a critical inflection point, and I look forward to working with my fellow board members to help shape a stronger, more sustainable future for everyone

    6/10/25 8:00:00 AM ET
    $ALHC
    Medical Specialities
    Health Care

    $ALHC
    $NXGN
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Alignment Healthcare Inc.

    SC 13G/A - Alignment Healthcare, Inc. (0001832466) (Subject)

    11/14/24 5:57:27 PM ET
    $ALHC
    Medical Specialities
    Health Care

    Amendment: SEC Form SC 13G/A filed by Alignment Healthcare Inc.

    SC 13G/A - Alignment Healthcare, Inc. (0001832466) (Subject)

    11/14/24 1:28:35 PM ET
    $ALHC
    Medical Specialities
    Health Care

    Amendment: SEC Form SC 13G/A filed by Alignment Healthcare Inc.

    SC 13G/A - Alignment Healthcare, Inc. (0001832466) (Subject)

    11/12/24 1:26:14 PM ET
    $ALHC
    Medical Specialities
    Health Care

    $ALHC
    $NXGN
    Financials

    Live finance-specific insights

    View All

    Alignment Healthcare Reports Fourth Quarter and Full-Year 2025 Results; Beats High-End of Guidance Across All Key Metrics

    Delivers full-year revenue of $3.95 billion, representing 46.1% growth year-over-year Exceeds high-end of fourth quarter and full-year guidance across all key metrics: membership, revenue, adjusted gross profit and adjusted EBITDARaises health plan membership guidance by 2,000 at the midpoint and introduces 2026 revenue guidance of $5.14 billion to $5.19 billion, representing 30%-31% growth year-over-year, and adjusted EBITDA of $133 million to $163 millionEarns recognition on the 2026 Fortune World's Most Admired Companies™ list, underscoring the company's innovative approach to senior health care ORANGE, Calif., Feb. 26, 2026 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (NASDAQ:ALHC),

    2/26/26 4:01:00 PM ET
    $ALHC
    Medical Specialities
    Health Care

    Alignment Healthcare to Announce Fourth Quarter and Full-Year 2025 Financial Results and Host Conference Call Thursday, Feb. 26, 2026

    ORANGE, Calif., Feb. 05, 2026 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (NASDAQ:ALHC), will release its fourth quarter and full-year 2025 financial results on Thursday, Feb. 26, 2026, after market close. Following the release, the company will host a conference call to review its financial results at 5 p.m. EST. Conference Call DetailsA live audio webcast will be available online at https://ir.alignmenthealth.com/. At the start of the conference call, participants may access the webcast at the following link: https://edge.media-server.com/mmc/p/kd529mia A replay of the call will be available via webcast for on-demand listening shortly after the completion of the call at the same we

    2/5/26 8:00:00 AM ET
    $ALHC
    Medical Specialities
    Health Care

    Alignment Healthcare Reports Third Quarter 2025 Results, Surpasses High-End of Guidance Across All Key Metrics

    Reports Q3 revenue of $993.7 million, up 43.5% year-over-yearBeats high end of third quarter guidance and raises full-year outlook across all key metrics: membership, revenue, adjusted gross profit and adjusted EBITDAHas 100% of members in plans rated 4 stars or higher for second consecutive year in 2026, including two 5-star contracts in Nevada and North Carolina and a 4.5-star contract in Texas ORANGE, Calif., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (NASDAQ:ALHC), today reported financial results for its third quarter ended September 30, 2025. "Our third quarter results mark the third consecutive quarter in which we surpassed the high end of our guidance across all

    10/30/25 4:01:00 PM ET
    $ALHC
    Medical Specialities
    Health Care